Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.037 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.038 | 0.9 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.9 |